Biogen Idec's James Mullen - CEO pay report

Biogen Idec CEO James Mullen

James Mullen - Biogen Idec

Total Compensation: $11.3 milion

Details: Mullen's package totaled about $11.3 million, including a 4 percent salary increase to almost $1.2 million and a cash bonus of $2.4 million, which came in at 24 percent over last year's. The biggest chunk of his compensation came as restricted stock and options valued at about $7.4 million when they were granted last February. The options are worth little now, however, because their strike price is higher than Biogen's current trade.

Biogen Idec News:
Icahn claims two Biogen seats, slams CEO
Amid proxy fight, Biogen chief earns $11.3M
Biogen Idec CEO James Mullen - CEO pay report

Biogen Idec's James Mullen - CEO pay report
Read more on

Suggested Articles

The drug failed a futility analysis in March, but Biogen resurrected it after factoring in data generated after the cutoff for the interim assessment.

The negative top-line data deal a big blow to the prospects of a drug analysts tipped to achieve blockbuster sales if it cleared phase 3.

Intrepida Bio launched with $9.5 million from Sofinnova and Canaan Partners to develop anti-BAG3 antibodies for the treatment of cancer.